| Title : Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies - Prive_2023_Eur.J.Nucl.Med.Mol.Imaging_50_1906 |
| Author(s) : Prive BM , Boussihmad MA , Timmermans B , van Gemert WA , Peters SMB , Derks YHW , van Lith SAM , Mehra N , Nagarajah J , Heskamp S , Westdorp H |
| Ref : Eur J Nucl Med Mol Imaging , 50 :1906 , 2023 |
| Abstract : Prive_2023_Eur.J.Nucl.Med.Mol.Imaging_50_1906 |
| ESTHER : Prive_2023_Eur.J.Nucl.Med.Mol.Imaging_50_1906 |
| PubMedSearch : Prive_2023_Eur.J.Nucl.Med.Mol.Imaging_50_1906 |
| PubMedID: 36813980 |
Prive BM, Boussihmad MA, Timmermans B, van Gemert WA, Peters SMB, Derks YHW, van Lith SAM, Mehra N, Nagarajah J, Heskamp S, Westdorp H (2023)
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
Eur J Nucl Med Mol Imaging
50 :1906
Prive BM, Boussihmad MA, Timmermans B, van Gemert WA, Peters SMB, Derks YHW, van Lith SAM, Mehra N, Nagarajah J, Heskamp S, Westdorp H (2023)
Eur J Nucl Med Mol Imaging
50 :1906